Agent: Allergan, Inc.20090118248 - 3-alpha-hydroxy 21-n-heteroaryl-pregnane derivatives for modulation of brain excitability and a process for the production thereof: wherein R1 is an alkoxy group and R2 is an optionally substituted, N-attached heteroaryl.